Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection
Yazar
Dubnov-Raz, Gal
Maltezos, Efstratios
Mamun, Abdullah
Manabe, Toshie
Metan, Gökhan
Mickiene, Aukse
Mikic, Dragan
Mohn, Kristin G.
Oliva, Maria E.
Ozkan, Mehpare
Parekh, Dhruv
Paul, Mical
Rath, Barbara A.
Refaey, Samir
Rodriguez, Alejandro H.
Sertogullarindan, Bunyamin
Skret-Magierlo, Joanna
Somer, Ayper
Talarek, Ewa
Tang, Julian W.
To, Kelvin
Dat Tran, Dat Tran
Uyeki, Timothy M.
Vaudry, Wendy
Vidmar, Tjasa
Zarogoulidis, Paul
Nguyen-Van-Tam, Jonathan S.
Hoeger, Peter H.
Hu, Xiao Yun
Islam, Quazi T.
Higuera Iglesias, Anjarath Lorena
Bassetti, Matteo
Beovic, Bojana
Bertisch, Barbara
Bonmarin, Isabelle
Booy, Robert
Borja-Aburto, Victor H.
Burgmann, Heinz
Cao, Bin
Carratala, Jordi
Chinbayar, Tserendorj
Cilloniz, Catia
Denholm, Justin T.
Dominguez, Samuel R.
Duarte, Pericles A. D.
Fanella, Sergio
Gao, Zhancheng
Gerardin, Patrick
Giannella, Maddalena
Gubbels, Sophie
Herberg, Jethro
Venkatesan, Sudhir
Myles, Puja R.
Bolton, Kirsty J.
Muthuri, Stella G.
Al Khuwaitir, Tarig
Anovadiya, Ashish P.
Azziz-Baumgartner, Eduardo
Bajjou, Tahar
Jimenez, Mirela F.
Keijzers, Gerben
Khalili, Hossein
Kusznierz, Gabriela
Kuzman, Ilija
Langenegger, Eduard
Lankarani, Kamran B.
Leo, Yee-Sin
Libster, Romina P.
Linko, Rita
Madanat, Faris
Üst veri
Tüm öğe kaydını gösterÖzet
Background. The effect of neuraminidase inhibitor (NAI) treatment on length of stay (LoS) in patients hospitalized with influenza is unclear.
Koleksiyonlar
- Makale [92796]